Funding for this research was provided by:
National Institute of Mental Health (RO1MH110192)
National Institute of Allergy and Infectious Diseases (RO1MH110192)
National Institute of Diabetes and Digestive and Kidney Diseases (5 T35 DK 104689-5)
Received: 25 January 2022
Accepted: 18 May 2022
First Online: 25 July 2022
: Study procedures were reviewed and approved by the Yale University Institutional Review Board (IRB protocol number 1609018355). Research staff reviewed the risks and benefits of participation with each participant, and participants provided written consent to participate in this study.
: The written consent provided by each participant included the possibility for the publication of de-identified data. This manuscript does not include any individual data associated with identifying information. Additionally, participants were reminded of the potential for publication by interviewers when they were asked to choose a pseudonym for use in final publications.
: The authors declare that they have no competing interests.